Multiple assembly pathways underlie amyloid-β fibril polymorphisms

Journal of Molecular Biology

Volumn 352, Issue 2, 2005, Pages 282-298

  Goldsbury, Claire ^a,c   Frey, Peter ^b   Olivieri, Vesna ^a   Aebi, Ueli ^a   Müller, Shirley A ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b NOVARTIS PHARMA AG   (Switzerland)

^c MAX PLANCK UNIT FOR STRUCTURAL MOLECULAR BIOLOGY   (Germany)

Author keywords

Alzheimer's disease; Amyloid protein; Fibril formation; Oligomer; Protofibrils

Indexed keywords

AMYLOID BETA PROTEIN;

ARTICLE; ATOMIC FORCE MICROSCOPY; DATA ANALYSIS; GENETIC POLYMORPHISM; MOLECULAR MODEL; MOLECULAR WEIGHT; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY;

EID: 24044507958     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2005.07.029     Document Type: Article

References (60)

1. J. Hardy, and D.J. Selkoe The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapy Science 297 2002 353 356
2. C. Haass Take five-BACE and the γ-secretase quartet conduct Alzheimer's amyloid β-peptide generation EMBO J. 23 2004 483 488
3. D.J. Selkoe Alzheimer's disease: genes, proteins, and therapy Physiol. Rev. 81 2001 741 766
4. D.M. Walsh, and D.J. Selkoe Oligomers in the brain: the emerging role of soluble protein aggregates in neurodegeneration Protein Pept. Letters 11 2004 213 228
5. H. LeVine III Thioflavin T interaction with synthetic Alzheimer's disease β-amyloid peptides: detection of amyloid aggregation in solution Protein Sci. 2 1993 404 410
6. A. Lomakin, D.B. Teplow, D.A. Kirschner, and G.B. Benedek Kinetic theory of fibrillogenesis of amyloid β-protein Proc. Natl Acad. Sci. USA 94 1997 7942 7947
7. D.M. Walsh, A. Lomakin, G.B. Benedek, M.M. Condron, and D.B. Teplow Amyloid β-protein fibrillogenesis. Detection of a protofibrillar intermediate J. Biol. Chem. 272 1997 22364 22372
8. D.M. Walsh, D.M. Hartley, Y. Kusumoto, Y. Fezoui, M.M. Condron, and A. Lomakin Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates J. Biol. Chem. 274 1999 25945 25952
9. J.D. Harper, C.M. Lieber, and P.T. Lansbury Jr Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-beta protein Chem. Biol. 4 1997 951 959
10. J.D. Harper, S.S. Wong, C.M. Lieber, and P.T. Lansbury Jr Assembly of Aβ amyloid protofibrils: an in vitro model for a possible early event in Alzheimer's disease Biochemistry 38 1999 8972 8980
11. M.P. Lambert, A.K. Barlow, B.A. Chromy, C. Edwards, R. Freed, and M. Liosatos Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins Proc. Natl Acad. Sci. USA 95 1998 6448 6453
12. M. Nybo, S.E. Svehag, and E. Holm Nielsen An ultrastructural study of amyloid intermediates in Aβ1-42 fibrillogenesis Scand. J. Immunol. 49 1999 219 223
13. W.B. Stine Jr, S.W. Snyder, U.S. Ladror, W.S. Wade, M.F. Miller, and T.J. Perun The nanometer-scale structure of amyloid-beta visualized by atomic force microscopy J. Protein Chem. 15 1996 193 203
14. G. Bitan, A. Lomakin, and D.B. Teplow Amyloid β-protein oligomerization J. Biol. Chem. 276 2001 35176 35184
15. G. Bitan, M.D. Kirkitadze, A. Lomakin, S. Vollers, G.B. Benedek, and D.B. Teplow Amyloid β-protein assembly: Aβ40 and Aβ42 oligomerize through distinct pathways Proc. Natl Acad. Sci. USA 100 2003 330 335
16. M.R. Nichols, M.A. Moss, D.K. Reed, W.L. Lin, R. Mukhopadhyay, J.H. Hoh, and T.L. Rosenberry Growth of beta-amyloid(1-40) protofibrils by monomer elongation and lateral association. Characterization of distinct products by light scattering and atomic force microscopy Biochemistry 41 2002 6115 6127
17. R.M. Murphy, and M.M. Pallitto Probing the kinetics of beta-amyloid self-association J. Struct. Biol. 130 2000 109 122
18. W.P. Esler, E.R. Stimson, J.R. Ghilardi, H.V. Vinters, J.P. Lee, P.W. Mantyh, and J.E. Maggio In vitro growth of Alzheimer's disease beta-amyloid plaques displays first-order kinetics Biochemistry 35 1996 749 757
19. C.S. Goldsbury, S. Wirtz, S.A. Müller, S. Sunderji, P. Wicki, U. Aebi, and P. Frey Studies on the in vitro assembly of Aβ1-40: implications for the search for Aβ fibril formation inhibitors J. Struct. Biol. 130 2000 217 231
20. O.N. Antzutkin, R.D. Leapman, J.J. Balbach, and R. Tycko Supramolecular structural constraints on Alzheimer's beta-amyloid fibrils from electron microscopy and solid-state nuclear magnetic resonance Biochemistry 41 2002 15436 15450
21. H.K. Blackley, G.H. Sanders, M.C. Davies, C.J. Roberts, S.J. Tendler, and M.J. Wilkinson In situ atomic force microscopy study of beta-amyloid fibrillization J. Mol. Biol. 298 2000 833 840
22. P.M. Gorman, C.M. Yip, P.E. Fraser, and A. Chakrabartty Alternate aggregation pathways of the Alzheimer beta-amyloid peptide: Abeta association kinetics at endosomal pH J. Mol. Biol. 325 2003 743 757
23. J. Bieschke, Q. Zhang, E.T. Powers, R.A. Lerner, and J.W. Kelly Oxidative metabolites accelerate Alzheimer's amyloidogenesis by a two-step mechanism, eliminating the requirement for nucleation Biochemistry 44 2005 4977 4983
24. T. Kowalewski, and D.M. Holtzman In situ atomic force microscopy study of Alzheimer's beta-amyloid peptide on different substrates: new insights into mechanism of beta-sheet formation Proc. Natl Acad. Sci. USA 96 1999 3688 3693
25. A.T. Petkova, R.D. Leapman, Z. Guo, W.M. Yau, M.P. Mattson, and R. Tycko Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils Science 307 2005 262 265
26. S.J.T. Van Noort, K.O. Van Der Werf, B.G. De Grooth, N.F. Van Hulst, and J. Greve Height anomalies in tapping mode atomic force microscopy in air caused by adhesion Ultramicroscopy 69 1997 117 127
27. I. Wildhaber, H. Gross, A. Engel, and W. Baumeister The effects of air-drying and freeze-drying on the structure of a regular protein layer Ultramicroscopy 16 1985 411 422
28. M.J. Allen, N.V. Hud, M. Balooch, R.J. Tench, W.J. Siekhaus, and R. Balhorn Tip-radius-induced artifacts in AFM images of protamine-complexed DNA fibers Ultramicroscopy 42-44 1992 1095 1100
29. Markiewicz, P. (1988). Orientational dependency of atomic force microscopic images revealed by Alzheimer paired helical filaments. PhD Thesis, Department of Chemistry, University of Toronto. [See also www.weizmann.ac.il/ surflab/peter/phfpaper/index.html ].
30. C. Goldsbury, J. Kistler, U. Aebi, T. Arvinte, and G.J.S. Cooper Watching amyloid fibrils grow by time-lapse atomic force microscopy J. Mol. Biol. 285 1999 33 39
31. N. Muecke, R. Kirmse, T. Wedig, J.F. Leterrier, and L. Kreplak Investigation of the morphology of intermediate filaments adsorbed to different solid supports J. Struct. Biol. 150 2005 268 276
32. D.R. Howlett, A.E. Perry, F. Godfrey, J.E. Swatton, K.H. Jennings, and C. Spitzfaden Inhibition of fibril formation in beta-amyloid peptide by a novel series of benzofurans Biochem. J. 340 1999 283 289
33. C. Soto, E.M. Sigurdsson, L. Morelli, R.A. Kumar, E.M. Castano, and B. Frangione Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy Nature Med. 4 1998 822 826
34. W.L. Klein, G.A. Krafft, and C.E. Finch Targeting small Aβ oligomers: the solution to an Alzheimer's disease conundrum? Trends Neurosci. 24 2001 219 224
35. D.M. Hartley, D.M. Walsh, C.P. Ye, T. Diehl, S. Vasquez, and P.M. Vassilev Protofibrillar intermediates of amyloid β-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons J. Neurosci. 19 1999 8876 8884
36. A.E. Roher, M.O. Chaney, Y.M. Kuo, S.D. Webster, W.B. Stine, and L.J. Haverkamp Morphology and toxicity of Aβ-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease J. Biol. Chem. 271 1996 20631 20635
37. M. Hoshi, M. Sato, S. Matsumoto, A. Noguchi, K. Yasutake, N. Yoshida, and K. Sato Spherical aggregates of beta-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3beta Proc. Natl Acad. Sci. USA 100 2003 6370 6375
38. L.L. Iversen, R.J. Mortishire-Smith, S.J. Pollack, and M.S. Shearman The toxicity in vitro of β-amyloid protein Biochem. J. 311 1995 1 16
39. R.V. Ward, K.H. Jennings, R. Jepras, W. Neville, D.E. Owen, and J. Hawkins Fractionation and characterization of oligomeric, protofibrillar and fibrillar forms of β-amyloid peptide Biochem. J. 348 2000 137 144
40. B.A. Yankner Mechanisms of neuronal degeneration in Alzheimer's disease Neuron 16 1996 921 932
41. D.M. Walsh, I. Klyubin, J.V. Fadeeva, M.J. Rowan, and D.J. Selkoe Amyloid-βoligomers: their production, toxicity and therapeutic inhibition Biochem. Soc. Trans. 30 2002 552 557
42. Q. Wang, D.M. Walsh, M.J. Rowan, D.J. Selkoe, and R. Anwyl Block of long term potentiation by naturally secreted and synthetic amyloid beta-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5 J. Neurosci. 24 2004 3370 3378
43. H. Akiyama, S. Barger, S. Barnum, B. Bradt, J. Bauer, and G.M. Cole Inflammation and Alzheimer's disease Neurobiol. Ageing 21 2000 383 421
44. D.T. Winkler, L. Bondolfi, M.C. Herzig, L. Jann, M.E. Calhoun, and K.H. Wiederhold Spontaneous hemorrhagic stroke in a mouse model of cerebral amyloid angiopathy J. Neurosci. 21 2001 1619 1627
45. H. LeVine, and J.D. Scholten Screening for pharmacologic inhibitors of amyloid fibril formation Methods Enzymol. 309 1999 467 476
46. M.A. Findeis, and S.M. Molineaux Design and testing of inhibitors of fibril formation Methods Enzymol. 309 1999 476 488
47. B. De Strooper, and G. König Alzheimer's disease - a firm base for drug development Nature 402 1999 471 472
48. D. Schenk, R. Barbour, W. Dunn, G. Gordon, H. Grajeda, and T. Guido Immunization with amyloid-βattenuates Alzheimer-disease-like pathology in the PDAPP mouse Nature 400 1999 173 177
49. M.A. Findeis Approaches to discovery and characterization of inhibitors of amyloid beta peptide polymerization Biochim. Biophys. Acta 1502 2000 76 84
50. C.S. Goldsbury, G.J.S. Cooper, K.N. Goldie, E. Saafi, S.A. Müller, and A. Engel Polymorphic fibrillar assembly of human amylin J. Struct. Biol. 119 1997 17 27
51. C. Goldsbury, K. Goldie, J. Pellaud, J. Seelig, P. Frey, and S.A. Müller Amyloid fibril formation from full-length and fragments of amylin J. Struct. Biol. 130 2000 352 362
52. A. Kajava, U. Aebi, and A. Steven The parallel superpleated beta-structure as a model for amyloid fibrils of human amylin J. Mol. Biol. 348 2005 247 252
53. J.D. Green, C. Goldsbury, J. Kistler, G.J.S. Cooper, and U. Aebi Human amylin oligomer growth and fibril elongation define two distinct phases in amyloid formation J. Biol. Chem. 279 2004 12206 12212
54. T. Ban, D. Hamada, K. Hasegawa, H. Naiki, and Y. Goto Direct observation of amyloid fibril growth monitored by thioflavin T fluorescence J. Biol. Chem. 278 2003 16462 16465
55. T. Ban, M. Hoshino, S. Takahashi, D. Hamada, K. Hasegawa, H. Naiki, and Y. Goto Direct observation of Abeta amyloid fibril growth and inhibition J. Mol. Biol. 344 2004 757 767
56. R.H. Takahashi, E.E. Nam, M. Edgar, and G.K. Gouras Alzheimer beta-amyloid peptides: normal and abnormal localization Histol. Histopathol. 17 2002 239 246
57. P.A. Merz, H.M. Wisniewski, R.A. Somerville, S.A. Bobin, C.L. Masters, and K. Iqbal Ultrastructural morphology of amyloid fibrils from neuritic and amyloid plaques Acta Neuropathol. 60 1983 113 124
58. R.D. Terry, N.K. Gonatas, and M. Weiss Ultrastructural studies in Alzheimer's presenile dementia Am. J. Pathol. 44 1964 269 297
59. A. Engel, R. Eichner, and U. Aebi Polymorphism of reconstituted human epidermal keratin filaments: determination of their mass-per-length and width by scanning transmission electron microscopy (STEM) J. Ultrastruct. Res. 90 1985 323 335
60. S.A. Müller, K.N. Goldie, R. Buerki, R. Haering, and A. Engel Factors influencing the precision of quantitative scanning transmission electron microscopy Ultramicroscopy 46 1992 317 334